Hello. I’m Dr. Maurie Markman from Cancer Treatment Centers of America in Philadelphia. I wanted to briefly discuss an interesting and important topic in the world of genomic medicine.
This relates to the question that might be asked of oncologists or primary care doctors who have a patient or a family in which it is known that there is an abnormality that increases the risk for a particular cancer, such as a BRCA1 mutation [and the risk for breast and ovarian cancer], and whether factors that have been identified in the general population as being either protective or potentially harmful in terms of risk also pertain to the individual with the genetic abnormality increasing risk.
Read the full, original story: BRCA and Risk for Ovarian Cancer: There’s More to the Story
